Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) plus apatinib versus DEB-TACE alone in treating huge hepatocellular carcinoma patients

BACKGROUND: Apatinib, a tyrosine kinase inhibitor, inhibits angiogenesis under the tumor hypoxic environment induced by drug-eluting bead transarterial chemoembolization (DEB-TACE), which is hypothesized to have synergic effect with DEB-TACE in treating hepatocellular carcinoma (HCC) patients. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ningjie, Chen, Jiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671984/
https://www.ncbi.nlm.nih.gov/pubmed/35083645
http://dx.doi.org/10.1007/s11845-021-02884-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671984/
https://www.ncbi.nlm.nih.gov/pubmed/35083645
http://dx.doi.org/10.1007/s11845-021-02884-w

Ejemplares similares